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ABSTRACT
ANNONACIN IN ASIMINA TRILOBA FRUIT:
IMPLICATIONS FOR NEUROTOXICITY

Lisa F. Potts
November 28, 2011
The acetogenin annonacin, from the tropical annonaceous plant Annona
muricata, is a lipophilic, mitochondrial complex I inhibitor reported to be more
toxic than rotenone to mesencephalic neurons. The temperate annonaceous
plant Asimina tri/oba (pawpaw) is native to the Eastern United States and its
products are available online. This study determined whether annonacin is in the
pawpaw fruit pulp and whether it or the crude ethyl acetate (EtOAc) extract is
toxic to cortical neurons and induces pathological changes in the microtubule
associated protein tau.
Pawpaw extract was prepared by pulp extraction with methanol and liquidliquid partitioning with EtOAc. Annonacin was isolated from the crude EtOAc
extract via column chromatography using a gradient solvent system of increasing
polarity. Mass spectroscopy, nuclear magnetic resonance and infrared

v

spectroscopy were used to compare isolated material with synthetic annonacin
and a natural annonacin sample. Toxicity of isolated annonacin and the total
EtOAc extract were determined in primary rat cortical neurons using the MIT (3(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. The effects of
annonacin on tau phosphorylation were determined by immunocytochemistry and
western blot analysis.
The average concentration of annonacin in the fruit pulp was 0.07 ± 0.03

mg/g. Purified annonacin (30.07 !-Ig/ml) and crude EtOAc extract (47.96 !-I9/ml)
reduced relative viability of cortical neurons by 50% 48 hours post treatment.
Annonacin toxicity was enhanced in the presence of crude extract. Annonacin
treatment resulted in a decrease in the neuronal specific marker microtubule
associated protein 2 (MAP2) and tau immunoreactivity, and tau expression was
decreased on western blot.
In conclusion, Asimina triloba fruit contains a high concentration of
annonacin, which is toxic to cortical neurons. Based on these results, annonacin
acts to reduce overall levels of tau, though it remains elusive whether or not this
is a direct or indirect effect of annonacin action. Crude fruit extract also induced
neurotoxicity, highlighting the need for additional studies to determine the
bioavailability after consumption and potential risks of neurodegeneration
associated with chronic exposure to pawpaw products.
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CHAPTER I
INTRODUCTION

Annonaceous acetogenins (ACGs), specifically annonacin, isolated from
Annona muricata (An. muricata) fruit, bark and leaves are naturally occurring
compounds exhibiting a range of biological activities related to inhibition of
mitochondrial complex I of the electron transport chain. 1-4 The annonaceous
plants have been investigated for their potential as cancer treatments,5-8 but also
for neurotoxicity due to their high content of acetogenins. 9 . 10 The purpose of this
project was to determine the presence and quantity of annonacin in Asimina
triloba (As. triloba) fruit pulp and assess annonacin and crude extract toxicity in
cultured cortical neurons, which are affected in a number of neurodegenerative
diseases.
Annonaceous Plants
The Annonaceae, or custard-apple, family consists of many different
genera including Annona and Asimina, each containing several species. The
United States Department of Agriculture provides a complete list of the 205
Annonaceae genera on the Germplasm Resources Information Network (GRIN,
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http://www.ars-grin .gov/cgi-bin/npgs/html/exgnlist.pl) including Annona (89) and
Asimina (12) individual species taxonomy. Most annonaceous plants are

confined to tropical or sub-tropical climates; however, the Asimina species are
also tolerant of temperate climates. 8

Figure 1. Asimina tri/oba (pawpaw) tree
at the University of Kentucky Arboretum in
Lexington, KY (2008).
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Specifically, As. triloba (Figure 1. pawpaw, papaw, prairie banana, poor
man's banana, dog banana, Ozark banana, Banango, also commonly referred to
as its native states "banana" e.g. Indiana/Hoosier banana, Kentucky banana) is
native to the Eastern United States and even southern parts of Canada making it
the only fruit-bearing annonaceous plant found abundantly throughout North
America (Figure 2).
The Annonaceae are widely studied due to their high concentrations of
cytotoxic alkaloids and acetogenins, which may be useful as anti-cancer, antifungal , anti-viral, and pesticidal agents. 3, 11-13 Annona muricata (Figure 3. An.
muricata, soursop, graviola, guanabana, Brazilian pawpaw, prickly custard apple)

is particularly well known for its medicinal use as an anti-cancer agent.?' 14
Recently, graviola was even featured on the popular Dr. Oz show for its
immunity-boosting properties http://www.doctoroz.com/videos/rainforestremedies-pt-2 , May 23 , 2011 ). As. triloba is also growing in popularity for its
potential use in alternative medicine and is being promoted for development as
an alternative cash crop to tobacco in some states. 15, 16

3

Figure 2. Distribution of As. triloba in North America. Map and related
information from the United States department of agriculture natural resources
conservation services is available online at http://plants.usda.gov.
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Figure 3. Annona muricata (soursop) tree. (image from
http://www.fruitipedia.com/soursop%20Annona%20muri
cata .htm)

Acetogenins
ACGs are a class of polyketide compounds containing , in most cases, a
long hydrocarbon chain and a terminaly-Iactone moiety (i.e. butenolide). Most
ACGs contain one or more tetrahydrofuran (THF) rings, (see Table 1 for a brief
list of bioactive annonaceous acetogenins). However, there are some without a
THF ring that may contain tetrahydropyran (THP) or epoxy rings or that are
linear.1 They are reported to be cytotoxic via mitochondrial complex-1 inhibition

5

and adenosine triphosphate (ATP) depletion. 8 Acetogenins can be found in
various organs of annonaceous plants, with seeds and bark having historically
been the most commonly studied. However, recent research on ACG content of
the Annonaceae has investigated the fruit with reports of acetogenins in both
soursop (Figure 4) and pawpaw (Figure 5) fruit pulp.

6

9,17

Table 1. Bioactive annonaceous acetogenins
ACG name- (MW)

Species

Organ

Mol.
Formula

THF profile

Asimicin (622)

As. tri/oba,
An. comifolia
As. tri/oba,
An. bullata,
An. comifolia,
R. mucosa
As. triloba
As. triloba
An. cherimolia,
An. bullata
As. triloba

Bark, roots, seeds, pulp.
Seeds.
Bark, pulp.
Bark.
Seeds.
Seeds.
Bark
Pulp.
Seeds.
Bark.
Seeds

C37Hss07

Adjacent bis-

THF
Stereochemistry
thltlthltlth

C37Hs607

Adjacent bis-

thltlthltler

C37H6607
C37H660S

Adjacent bis
Non-adjacent bis

thltler/clth
t/th-th/t/er

C35H6407

Mono

erltlth

As. triloba
An. muricata
An. densicoma
G.giganteus

Bark, seeds.
Pulp, bark, leaves
Seeds
Bark

C35Hs407

Mono

thltlth

C3sH6407

Mono

tlth-th

olU

Asitrilobin-C and
0(624)

As. tri/oba

Seeds

C37H6S07

Mono

thltlth

~

Squadiolin A (640)

An. squamosa

Seeds

C37H6aOa

Mono

erltlth

~<

Diepomuricanin-A
(546)

An. muricata

Seeds

C3sH6204

No THFs, rather bisepoxy rings

--

Butyrolactone-1
(390)

P. macrocarpa

Seeds

C2sH4203

Linear ACG with no
THFs

--

Bullatacin (a.k.a.
rolliniastatin-2)
(622)
Trilobacin (622)
Bullatalicin (a.k.a.
cherimolin-1 )
(638)
Asitrocin (596)
~

Annonacin (596)

Gigantetrocin-A
(596)
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Table 1. aNote this is not an exhaustive list; rather this highlights only a few of
the numerous annonaceous acetogenins with reported bioactivity. See
references 1, 7 and 8 for thorough reviews of acetogenins and their bioactivities.
THF stereochemistry refers to the stereochemistry of the bonds between the
hydroxyl groups and the THF ring(s) and between the THF rings. Abbreviations:
As.

=Asimina, An. =Annona, R. =Rollinia, G. =Goniothalamus, P. =Pha/eria; th

=threo, t =trans, er =erythro, c =cis.
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Figure 4. Soursop fruit on tree.

(http://www.fruitipedia.com/soursop%20
Annona%20muricata.htm

Figure 5. Pawpaw fruit on tree .

(http://www.meridian.k12.iI.us/middle%20school/st
udent worklrricker native trees/Pawpaw.html )
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Current research on the acetogenin content of As. tri/oba is focused on
bis-THFs indicating they are more cytotoxic than mono-THFs and therefore more
relevant to cancer research 4,8, 11 ,12, 17,35. Annonacin (Figure 6) is a mono-THF .
acetogenin found in the fruit, twigs, bark and leaves of An. muricata, and it is
reported to be neurotoxic

10 .

Figure 6. Structure of Annonacin: C35H6407.

Though annonacin has also been found in As. tri/oba, these studies focused on
parts of the plant that provided the most easily accessible extracts, such as twig
bark or seeds, rather than fruit. 18,27,28, 36 Annonacin has also been detected in
Paw-Paw Cell Reg™, a natural supplement prepared from As. tri/oba twig
extracts.8, 26

Public Health Significance
As noted above, the annonaceous plants As. tri/oba and An. muricata are
growing in popularity for various reasons including their potential use in the
treatment of cancer?' 8 Products from each of these plants are widely available
online for purchase year-round. The push to increase market awareness of As.
triloba products as well as the potential medicinal uses for acetogenins is evident

10

online and when reviewing the academic literature.

7,8,15-17,26

For example, in a

recent review of annonaceous acetogenins, Dr. Liaw notes the importance of
considering these compounds in drug developmene

In 27 years, more than 500 acetogenins were isolated from
various parts of the plants of this [AnnonaceaeJ family. These
bioactive acetogenins became more important, particularly in
pharmaceutical research. A great interest in investigating the
mechanisms of action of a series of acetogenins emerged from
the leaps in knowledge about the processes involved in tumour
cell death.

Members of this class of natural compounds are

regarded as "potentia/" candidates for future generations of
anti-cancer drugs. Acetogenins have become one of the most
interesting classes of natural products at present.

Such reports highlight the significance of determining the acetogenin
content of the pawpaw fruit and other plant products. This is especially crucial
considering reports of neurotoxicity associated with An. muricata, which has
been traced to the presence of annonacin. 10, 37 Specifically, regular consumption
of fruit and tea from tropical annonaceous plants was reported in two
epidemiologic studies to be higher in patients with progressive supranuclear
palsy (PSP) and with an unclassifiable atypical parkinsonian disorder than
controls in the French West Indies.

38-41

To date, neurotoxicity studies of the Annonaceae have focused either on
specific extracts from fruits other than pawpaw (e.g. soursop) or on pure
annonacin rather than on extracts from As. triloba.

11

5,6

Recent toxicity studies on

As. triloba have examined extracts other than annonacin and only considered
their usefulness as pesticides or cancer-preventing therapies without considering
potential neurotoxic effects.

3,11.12.42

Again, the focus of these studies has been

on extracts from those parts of the tree that potentially contain the highest
concentrations and most easily accessible extracts. The design and/or outcome
measures of these studies were not appropriate for assessing the risks of chronic
exposure to extracts or consumption of the fruit. Specifically, potentially
neurotoxic side effects could not be captured by these studies as safety/toxicity
was determined based strictly on weight loss or other behavioral changes.

8,42-44

However, as noted in Dr. Champy's studies, no behavioral abnormalities or
systemic effects could be detected in rats chronically exposed to annonacin at
concentrations high enough to produce widespread neurodegeneration. 5 Hence,
the toxicity studies on As. triloba extracts in cancer cells and tumors did not
consider the possible presence of neuropathology that may have resulted in
response to their treatment paradigms. Therefore, the acetogenin content of
pawpaw fruit and elucidation of its neurotoxic potential is an important public
health issue that should be investigated before pawpaw products become more
widely used in alternative medicine.

Relevance to Neurodegeneration
Though Parkinson's (PO) and Alzheimer's (AD) diseases represent the
most common neurodegenerative disorders affecting over 1.5 and 5 million
Americans respectively, there are a number of atypical parkinsonian disorders
12

(APDs) that are less common and not as widely researched including
tauopathies such as progressive supranuclear palsy (PSP), fronto-temporal
dementia with parkinsonism associated with chromosome 17 (FTDP-17) and
cortical basal degeneration (CBD). The distribution of degeneration and tau
pathology varies between tauopathies affecting brainstem and basal ganglia
nuclei as in PSP and CBD as well as cortical areas as seen in AD, CBD and
Pick's disease.

45-48

Understanding mechanisms of pathogenesis of these

diseases may provide useful information that can be translated to their
representative class of disorders (e.g. tauopathies, parkinsonian disorders) or
more broadly to the process of neurodegeneration.
Typical symptoms of PSP include early postural instability and falls,
vertical supranuclear gaze palsy and L-3,4-dihydroxyphenylalanine (L-DOPA)
unresponsive parkinsonism, therefore classifying it as an APD. 49-51 Additionally,
while there is loss of dopaminergic neurons in the substantia nigra, similar to PD,
the pathological hallmarks of PSP, which include the presence of
hyperphosphorylated tau aggregates depOSited in tufted astrocytes, and
neurofibrillary tangles (NFTs), more closely resembles AD and categorize it as a
tauopathy.52,53 Risk factors associated with the development of PSP are
therefore of interest as elucidation of PSP pathological mechanisms may provide
insight into the underlying pathologies of both PD and AD.
An.

muricata is reported to be neurotoxic due to its high content of

acetogenins and tetrahydroisoquinolones (TIQs), which are toxic to nigrostriatal
neurons by inhibiting mitochondrial complex-1. 3, 4, 54-56 This mechanism is similar
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to that following rotenone and 1-methyl 4-phenyl 1,2,3,6-tetrahydropyridine
(MPTP) exposure, which induce parkinsonism in humans and animal models and
are considered model neurotoxins (see Figure 7 for structures of relevant
compounds).57-60 MPTP toxicity is due to the production of the toxic metabolite
1-methyl-4-phenylpyridinium (MPP+), which requires active transport into the cell
via the dopamine transporter in order to induce mitochondrial inhibition and cell
death therefore rendering it a dopaminergic specific toxin. 61 Annonacin, the
major acetogenin of An. muricata, is more potent than MPTP and as effective as
rotenone at killing nigrostriatal neurons. 5, 62, 63 Unlike MPTP, annonacin toxicity is
not dependent upon the dopamine transporter and its toxicity is not specific to
dopaminergic cells as it also causes cell death in y-aminobutyric acid
containing(GABA) and cholinergic neurons. 5, 37, 56 To date, studies investigating
the neurotoxicity of annonacin were tested in cultured striatal or mesencephalic
neurons 5,6,37,55,63. This is an important distinction considering that cortical and
other non-dopaminergic neurons are widely affected in tauopathies. 45 , 46, 52
Exposure of mesencephalic dopaminergic neurons to the total extract of alkaloids
from An. muricata root bark and two of its most abundant sub-fractions
(coreximine and reticuline) resulted in degeneration of 50% of the dopaminergic
neurons one day later and this toxicity was also not dependent upon the
dopamine transporter. 55,56 Annonacin is much more potent than these alkaloids
at killing dopaminergic neurons. 6 Furthermore, recent reports suggest that
pawpaw extracts may be more toxic than extracts from soursop or cherimoya

(Annona cherimolia ).17

14

Relevant Complex-1 Inhibitors

coreximine

reticuline

annonacin

bullatacin

rotenone

Figure 7. Structures of some of the complex-1 inhibitors noted throughout the
text. Coreximine and reticuline are two alkaloids found in An . muricata that have
been tested for neurotoxicity.55 Annonacin and bullatacin are two acetogenins
with reported toxicity in various models.37 • 42 Rotenone and MPP+ are model
neurotoxins included for comparison.

15

Annonacin and Tau Pathology
Located on chromosome 17q21, the tau gene encodes the important
microtubule associated protein (MAP) tau, which is vital to microtubule dynamics
including assembly and stability. 64-66 In the human adult there are six different
tau isoforms expressed as a result of alternative splicing of exons 2, 3 and 10.
Depending on Exon 10 splicing, tau is expressed with either 3 or 4 repeats (3R or
4R) of microtubule binding domains (exon 10 inclusion

=4R).67

The ratio of 3R

to 4R is important in normal neuronal functioning and is disrupted in human
tauopathies. 68 ,69 Additionally, pathological tau is sufficient for inducing
neurodegeneration as evident by the association of mutations in chromosome 17
with fronto-temporal dementia with parkinsonism?O Furthermore, the MAPT H1
haploptype is associated with increased risk for PSp. 67 , 71 Therefore,
understanding the cause and effects of tau pathology is important for elucidating
the mechanisms of neurodegeneration in diseases with pathological tau
deposition.
Annonacin isolated from An. muricata has been reported to cause cell
death and tau pathology in mesencephalic cultures,37 and neurodegeneration of
the basal ganglia and brainstem after its chronic, intravenous administration to
rats 5. Nigrostriatal pathology, mitochondrial impairment and/or tau pathology are
seen in numerous neurodegenerative disorders including PO, AD and PSP. 45,72,
73 Accumulation of tau in the cell body is also seen in a number of tauopathies
including AD and PSp. 45 , 50, 52, 53, 72, 74, 75 It is reported that, along with cell death,
low concentration of annonacin results in the migration of the protein tau from the

16

axon to the cell body, increased tau protein levels, disruption of microtubules,
mitochondrial complex-1 inhibition and ATP depletion, which have all been
shown to occur in the aforementioned diseases. 37 , 45, 50, 52, 53, 72, 74, 75 These
studies support the hypothesis that annonacin and other acetogenins in As.
triloba are neurotoxic and may cause neurodegeneration.

Model neurotoxins are commonly used in vitro to gain a better
understanding of the role processes such as mitochondrial impairment, ATP
depletion, alterations in tau and microtubule disruption play in the development of
neuropathology?6 Rotenone and MPTP are both model "parkinsonian"
neurotoxins that have been shown to inhibit mitochondrial complex-1 and induce
protein aggregation and parkinsonism in vivo (see Table 2 for a brief list of
neurotoxins).57, 58, 63, 77-81 Eskobar-Khondiker et al. reported that annonacin's
inhibition of mitochondrial complex-1 is responsible for the redistribution of tau.
However, they also showed microtubule damage in response to annonacin
treatment, and prevention of complex-1 inhibition only partially protected
mesencephalic cultures from annonacin induced cell death?7 It was also
recently suggested that complex-1 inhibition may not be the primary mechanism
of neuronal cell death induced by rotenone, which has long been considered a
classical complex-1 inhibitor. 82 Furthermore, studies have demonstrated that
neurotoxins may adversely affect microtubule dynamics as a primary mechanism
of action in addition to inhibiting complex-1. 83 , 84
Tau may be phosphorylated at a number of serine and threonine residues,
some of which are found within the microtubule binding domains with many other

17

phosphorylation sites flanking this region (see reference 67 for review of tau
phosphorylation sites). Tau is hyperphosphorylated in paired helical filaments
(PHFs) and neurofibrillary tangles (NFTs). Glycogen synthase kinase (GSK)-3j3
is an intriguing target of study in tau pathogenesis since it is known to
phosphorylate tau at sites in and around the microtubule binding domain 85-87
GSK-3j3 may playa role in tau pathology as there is increased GSK-3j3
expression in tau inclusions of tauopathy patients compared to controls. 88
Additionally, rotenone is reported to activate GSK-3j3 and induce tau
hyperphosphorylation. 89 The effect of annonacin on kinase activation has not
been previously considered and may provide a better understanding of its
mechanism of action. While GSK-3j3 may playa role in the effects of annonacin
on complex-1 and consequent changes in tau, annonacin may also directly affect
it, which in turn may affect the phosphorylation state of tau and/or signal cell
death independently of complex-1 inhibition.
Sharing similarities with rotenone and MPTP as well as inducing
pathological changes in tau makes annonacin a compound of interest for
neurotoxicity studies. 37 . 55, 62 Human exposure to MPTP is currently uncommon
as it is a byproduct in the production of a synthetic narcotic. 59 Therefore, while it
may be a useful tool for mechanistic studies, it does not represent a probable risk
factor for idiopathic PO since widespread exposure is highly unlikely.

18

Table 2. N
-

-- -

-

--

Toxin
ROT
ROT
ROT
ROT, PQ,
MPP+
Soursop
Soursop

.....

-

--

-

--

-

-

-

f

t

d

Bioactivity
LC so =100nmol/L Complex-1 inhibition req'd.
2.5mg/kg/day = parkinsomism and widespread NO. Nigrostriatal cell death and tau
patholooy.
100nM ROT activated GSK313. Toxicity required GSK313
Wild type: 10nM ROT= 75% OAergic death and 33% complex-1 inhibition.
Complex-1 inhibition not required for toxicity of ROT, MPP or PO
OR for PSP = 20. PSP Symptoms improved after stopping annonaceous
consumption
Gd-PSP and -POC consumed more soursop (150g/life or 2g/kg AN) than controls or
PO (25g/life or O.4g/kg) (cummulative)

Soursop
(alkaloids)
TIQs

EC50 alkaloid totum=18ug/ml , apoptotic cell death, inhibition OA uptake that was
not required for toxicity
Decrease in striatal OA ipsi- and contralateral to lesion

Complex-1
inhibitors
AN

AN IC so complex-1= 55nM, EC oo ATP depletion= 134nM, ECoodeath= 60nM. MPP+
IC so = 2.6mM, EC oo ATP & death = 541JM. ROT ICoo , EC so ATP & death all = 7nM.
AN (3.8 or 7.6mg/kg/day) crosses BBB, inhibits complex-1, decreases ATP, and
causes nigro-striatal cell death
LC so = 50nM after 48hrs. ATP depletion, increased tau phosphorylation, somatic
redistribution of tau, retrograde transport of mitochondria and MT disruption.
30nM AN=IC so complex-1, EC oo for TH & MAP2+ cells = 0.0181JM & 0.0271JM AN,
0.034 & 0.0411JM ROT, 1.9 & 72IJM MPP+ respectively. Brainstem and nigrostriatal
lesions and dystrophic fibers.

\D

AN
AN

Experimental Model
SK-N-MC
chronic IV infusion to rats for 28 days
SK-N-MC
Wild type and Ndufs4 knockout
midbrain E14 mouse cultures
human consumption

Ref.
01

~"
H~

o.
~o. ~~

human consumption and brain imaging
on controls and PO, Gd-PSP and
GdPOC patients
E 16.5 rat mesencephalic culture

~u

7 day unilateral infusion into rat
striatum
E 16.5 rat striatal culture

~

00

O~

chronic IV infusion to rats for 28 days

~

E 16.5 rat striatal culture

~(

E 15.5 rat mesencephalic culture and
IV infusion of AN for 28 days

~.:>t>

=annonacin, ROT =rotenone,
PO =paraquat, TIO =tetrahydroisoquinolone, SK-N-MC =human neuroblastoma cell line, DA =dopamine, OR =odds
ratio, IC =inhibitory concentration, EC =effective concentration, MT =microtubule, Gd =Guadeloupian, PDC =
Parkinson-dementia complex, BBB =blood-brain barrier, TH =tyrosine hydroxylase.
For thorough review of complex-1 inhibiting neurotoxins see references 63 and 76. AN

Rotenone is still approved for use as a pesticide in the United States and
therefore represents a public health concern; however, though it does induce tau
aggregation, its toxic effects are not protein specific and therefore its usefulness
as a model compound translates more generally to neurodegeneration rather
than a particular disease or set of diseases as is the case with MPTP and PD. 37 ,
58,76,79

To date, annonacin has been shown to specifically induce tau pathology

and may therefore represent a novel model neurotoxin that is more etiologically
relevant to tauopathies than MPTP. 37 For these reasons, elucidation of
annonacin toxicity may provide valuable insight into to the pathogenesis of
tauopathies including those that present as APDs.

Research Aims
Considering that annonacin is present in other (e.g. An. muricata)
annonaceous fruits and is present in As. triloba bark, it was hypothesized that it
would also be present in the fruit pulp As. triloba (Le. pawpaw). Additionally,
while the toxic effects of extracts, including annonacin, from An. muricata have
been reported in striatal and midbrain cultures, it has not been determined
whether the extracts or annonacin from As. triloba share this toxicity in cortical
neurons, which are also affected in a number of the diseases noted above.
Considering the information discussed above regarding the presence of toxic
acetogenins in As. triloba and related plants, it was hypothesized that As. triloba
fruit would contain the neurotoxic acetogenin annonacin and that it would be toxic
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to cortical neurons. Furthermore, crude acetogenin-containing extract was
expected to be more toxic than annonacin due to the presence of multiple
bioactive acetogenins. Finally, it was hypothesized that annonacin would induce
changes in the tau protein as previously reported. The long-term goal of this
research is to provide insight into the mechanisms of pathogenesis of
neurodegenerative diseases to develop better treatment strategies for them. The
specific aims of this project were as follows:

AIM I: To determine the presence and concentration of

annonacin in pawpaw fruit pulp.
*Is the toxic acetogenin, specifically annonacin, present
in fruit pulp of Asimina triloba?
*Is annonacin present in the pawpaw fruit in high enough
concentration to induce neurotoxicity?
AIM II: To determine the toxicity of pawpaw fruit extracts in

primary cortical neurons.
* Is treatment with annonacin isolated from the pawpaw
fruit toxic to rat cortical cultures?
*Is treatment with total acetogenin-containing extracts
more toxic than pure annonacin?
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AIM III: To confirm the effect of annonacin on tau
phosphorylation.
*Ooes treatment with annonacin isolated from pawpaw
fruit result in tau hyperphosphorylation or accumulation?
*Ooes annonacin activate glycogen synthase kinase
(GSK)-3# as shown in most tauopathies?

The following chapters detail the methods used to investigate these
questions and discuss the results in relation to the current literature.
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CHAPTER II
MATERIALS AND METHODS

Extraction and isolation of annonacin from Asimina tri/oba fruit pulp
Frozen pawpaw pulp was purchased from Integration Acres, Ltd. Fresh
pawpaws were purchased from A Little Piece of Paradise Farm, Kings Mountain,
Kentucky. A sample of annonacin isolated from An. muricata was kindly donated
by Dr. Pierre Champy, Faculte de Pharmacie, Chatenay-Malabry, France, as a
sample for purposes of comparison with As. tri/oba extracts. Solvents and
reagents were American Chemical Society (ACS) grade and used as
commercially supplied (VWR). Analytical thin-layer chromatography (TLC)
utilized 0.25 mm pre-cut glass-backed plates (Merck, Silica Gel 60 F254). Thinlayer chromatograms were visualized during chromatographic and extraction
runs by rapidly dipping the plates in anisaldehyde/ethanol/sulfuric acid stain and
heating (hot plate). A second technique involved dipping the plates in 3,5dintrobenzoic acid/methanol (2%) and heating followed by dipping in
KOH/methanol (Kedde reagent). The Kedde reagent specifically stains
acetogenins due to its butenolide reactivity; however, it is far less sensitive than
anisaldehyde staining, which is not acetogenin specific. Therefore, anisaldehyde
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stain was preferentially used to analyze fractions as they were eluted. Gravitycolumn chromatography was carried out using silica gel 60 (E. Merck 9385, 235400 mesh) or silica gel 62 (Mallinckrodt 6551,60-200 mesh). Extracts and
chromatographic fractions were concentrated with a BOchi rotavapor under water
aspirator vacuum. High Resolution Mass Spectral (HRMS, specifically FTMS
using ESI) data were measured with a Thermo Electron Corporation LTQ-FT.
Nuclear magnetic resonance (500 MHz 1H and 13C NMR) spectra were recorded
with Varian INOVA 500 or VNMRS 400 instruments using deuterated
dicholormethane (CDC b) as a solvent and internal standard. Infrared spectra
(Fourier-transform infrared spectroscopy, FTIR) were recorded with a PerkinElmer Spectrum 100 instrument. Optical rotations were recorded with a JASCO
Dip-370 polarimeter.

(5S)-5-Methyl-l-[(2R,SR, 1lR)-2,S,1l-trihydroxy-1l-[(2R,5R)-5-[(1 R)-1hydroxytridecyl]-2-tetrahydrofuranyl] tridecyl]-5H-furan-2-one. Annonacin
(AN): Fresh (peeled and seeded fruit) or frozen fruit pulp (1000 g) was
homogenized in methanol (800 mL) using a commercial blender. The yellowgreen methanolic homogenate was stored overnight under refrigeration. The
homogenate was then vacuum-filtered with a 150 mm diameter Buchner funnel
and the filter cake was washed with 50% aqueous methanol in portions (600 mL,
total) and the application of vacuum was continued after the washing process
until the sturdy filter cake was slightly damp. The resulting yellow-orange filtrate
was then poured into a separatory funnel (2000 mL) and extracted with ethyl
acetate (EtOAc, 3x200 mL) whereupon brine was added as needed to enhance
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the separation of aqueous methanol and organic EtOAc layers. The crude ethyl
acetate extracts were combined and the yellow solution was dried over
anhydrous sodium sulfate (30g) overnight (10°C). The drying agent was
removed by vacuum filtration directly into a 1000 mL recovery flask while
washing with fresh ethyl acetate (100 mL). The clear, deep yellow filtrate was
concentrated by rotary evaporation in vacuo at room temperature (rt). During the
concentration process, a white precipitate, presumably carbohydrate components
of the crude extract due to its water solubility, was evident and was removed by
vacuum filtration while washing with ethyl acetate. The resultant filtrate (crude
ethyl acetate extract, cEX) was concentrated under vacuum pressure and the
odorous orange-yellow oil (SOO mg) was kept under refrigeration until submission
to column chromatography. The concentrated oily cEX was applied to a 2SxSOO
mm glass column packed with silica gel (2S0mm) and eluted sequentially with
hexane/ethyl acetate (S:1, SOO mL), hexane/ethyl acetate (2: 1, 200mL),
hexane/ethyl acetate (1:2, 200 mL), ethyl acetate (100%,100 mL) and ethyl
acetate/methanol (9S:S, SOO mL). Elution analysis of the individual fractions was
conducted by TLC with visualization by anisaldehyde stain. The fractions
bearing annonacin, a less-mobile component and two more mobile components
were combined and concentrated under vacuum. The combined oily,
chromatographed concentrate was submitted to a second column
chromatography using the same volume of silica gel and eluted with hexane/ethyl
acetate (1 :1,200 mL), hexane/ethyl acetate (1 :2,300 mL) and ethyl
acetate/methanol (9S:S, 300 mL) again testing each fraction by TLC. The
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occurrence of a persistent higher-running component necessitated a third
chromatographic run using the same conditions as the second. Final annonacin
and acetogenin containing fractions were identified by TLC visualized with
anisaldehyde and Kedde staining and weight determined following solvent
removal in vacuo. FTMS and NMR were used to compare the isolated
annonacin to an annonacin sample from An. muricata and synthetic annonacin
data. 90

(5S)-5-Methyl-3-[(2R,SR, 13R)-2,S, 13-triacetoxy-13-[(2R,5R)-5-[(1 R)-1acetoxytridecyl]-2-tetrahydrofuranyl] tridecyl]-5H-furan-2-one. Annonacin
tetra acetate (AN-Ac): Crude annonacin (79 mg, 0.13 mmol) was dissolved in
pyridine (200 jJL, 2.5 mmol) and then acetic anhydride (100 jJL, 1.0 mmol) was
added by syringe. The reaction mixture was stirred (48h, rt) whereupon TLC
(hexanes/ethyl acetate, 2:1) indicated complete consumption of starting material
and formation of a higher-running spot. The reactants were removed under high
vacuum and the viscous residue was dissolved in dichloromethane and applied
to a gravity silica gel column. Elution of the column with hexanes/ethyl acetate,
2: 1 followed by combination and concentration of the fractions yielded the
annonacin tetraacetate derivative. The spectral data was compared to that of
isolated annonacin. Optical rotations and infrared spectra (FTIR) were also
recorded for samples of annonacin and annonacin tetraacetate.
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In vitro toxicity of annonacin and Asimina triloba organic fruit extract
and effects on microtubule associated protein tau
Known amounts of purified annonacin and cEX were dissolved in dimethyl
sulfoxide (DMSO) or ethyl acetate (EtOAc) to make 50 mM and 75mg/ mL stock
solutions respectively, which were stored at -80°C. Acetogenin-free fractions
(ACG-free) isolated from cEX alongside annonacin were diluted in DMSO to 22
mgt mL and stored at -80°C. Stock solutions of 1mM rotenone (Sigma R8875)
were prepared in DMSO or EtOAc prior to each experiment. Serial dilutions of
drugs were prepared in basal medium Eagle (BME, Sigma) immediately before
each experiment. Reagents used for neuronal cultures and analytical techniques
were used as commercially supplied or prepared fresh according to manufacturer
protocols and pH adjusted to 7.4 with sodium hydroxide.
Cell Cultures. Cortical neurons were cultured from newborn SpragueDawley rat pups on postnatal day 0 (PO) according to previously published
methods. 91 The handling of animals followed Institutional Animal Care and Use
Committee approved procedures. For viability assays, cultured neurons were
plated in 96-well culture plates coated with poly-D-Iysine (POL, 5%) at a density
of 4.8-6.4 x 104 cells/ well. For immunocytochemistry, cells were plated at a
density of 0.5 x 106 cells/ well in 24-well plates with POL and laminin coated
glass coverslips. For western blotting, cells were plated in 35 or 60 mm culture
dishes coated with POL at densities of 2.0 or 4.0 x 106 cells/ well respectively. 1-
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(~-D-Arabinofuranosyl)

cytosine (Ara-C, 2.S I-lM) was added to all wells on day 2

in vitro (DIV 2) to inhibit proliferation of non-neuronal cells.
Cells were treated with annonacin, cEX, ACG-free extract, rotenone or
vehicle (DMSO or EtOAc) on DIV S. The amount of DMSO in control cultures did
not exceed O.S% unless otherwise noted. The toxicity of EtOAc, as well as
MeOH and ethanol (EtOH), was tested against the typical vehicle control, DMSO,
prior to performing experimental treatments with EtOAc. ACG-free extract
served as a negative control for the extraction process. These fractions were
considered to be ACG free due to the fact that they lacked Kedde positive
staining when heavily spotted on TLC. In addition to being Kedde negative,
these fractions were chosen as negative controls because they eluted closely
with the annonacin containing fractions therefore representing the most similarly
processed extracts.
Rotenone toxicity in cortical and midbrain neurons varies depending on
the experimental paradigm, with reported toxicity ranging from low nanomolar to
micromolar concentrations. 63. 77. 92-97 Considering these varying reports, and that
high concentrations of rotenone may induce cell death via different
mechanisms,96 1flM rotenone was used as a positive control for neurotoxicity.

Viability Assay. MTT (3-(4,S-dimethylthiazol-2-yl)-2,Sdiphenyltetrazolium bromide) is converted to a formazan product by
mitochondrial dehydrogenase in live cells. As the rate of conversion is
proportional to the number of surviving cells, it provides a convenient measure of
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cell viability.98, 99 Therefore, the MIT assay was used as previously described to
assess the toxicity of each treatment relativeto vehicle-treated controls. 1oo Fortyeight hours post-treatment MTT was added to 96-well plates and incubated for 2
hours followed by overnight solubilization in 1:1 N,N-dimethylformamide and
sodium dodecyl sulfate (SDS, 20% in di-H20). Absorbance was determined at
570nm with a Spectra Max spectrophotometer and analyzed with Soft-max pro.
Immunocytochemistry. Cells were fixed with 4% paraformaldehyde at 0,
8, 24, and 48 hours and immunostained following standard procedures91 with
rabbit anti-MAP2 (microtubule associated protein 2) polyclonal antibody (Cell
Signaling Technologies #4542, 1:200), mouse anti-total tau (DA9, 1:500), anti-tau
phosphorylated at serines 396 and 404 (PHF-1, 1:500), anti-tau phosphorylated
at serine 202 (CP-13, 1:500) or anti-tau conformational epitope MC-1 (recognizes
amino acids 7-9 and 326-333, 1:100) monoclonal antibodies (all tau antibodies
were kindly provided by Dr. Peter Davies, Albert Einstein College of Medicine).
IGg, secondary antibodies used included goat anti-mouse Texas Red
(Calbiochem #401218), AlexaFluor #488 goat anti-mouse or goat anti-rabbit
(Invitrogen #A 11029 and A 11034, respectively). Nuclear chromatin was costained with Hoechst 33258 (Sigma). Images were captured on a Zeiss
AxioObserver A.1 inverted light microscope with a Zeiss AxioCam MRM canon
camera using AxioVision 4 software.
Western Blot Analysis. At 1, 4, 8, and 24 hours after treatment, cells
were lysed with SDS lysis buffer and stored at -20°C. Equal amounts of cell
Iysates were run on 10% acrylamide gels according to standard laboratory
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procedures. 91 , 101 The tau antibodies noted above were used to probe for total
and phospho-tau epitopes. Anti-GSK-3~ total (cell signaling #9332, rabbit
1:1000) and -phospho-serine 9 (Biosource #44-600G, rabbit 1:1000) were used
to probe for total and inactive GSK-3~. Anti-~-actin (Sigma #A5316, mouse
1:2000) was used as a loading control for each probe. Secondary horseradish
peroxidase conjugated mouse and rabbit antibodies were used according to
manufacturer's protocol (CalBiochem #402335 and #401315, respectively,
1: 10,000). Protein expression was quantified by iIIuminescence on a Kodak
Image Station 4000R using GE software and normalized to loading controls.
Statistical Analysis. Absorbance of treated cells was normalized to
controls for each 96-well plate. The raw values normalized to vehicle-treated
controls were used to determine relative viability of treated cells. Annonacin
toxicity was determined from a total of 13 independent experiments (22 total 96well plates). cEX and ACG-free treatments were tested in a total of 3
independent experiments (3 and 5 total 96-well plates respectively). In some
instances multiple 96-well plates were used as replicates within that experiment,
hence the above indication of the total number of plates. On each 96-well plate,
6 replicate wells (or sister cultures) were used per treatment. Rotenone was
included as a positive control on each plate. The mean, 95% confidence
intervals, and p-values were determined for each treatment using Graph-Pad
prism software. One-way analysis of variance (AN OVA) followed by Dunnette's
post-hoc test was used to determine significance, and non-linear regression
analysis to calculate the LDso of annonacin.
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Lysates from a total of 4 independent experiments were analyzed via
Western blot. Background was subtracted from each lane and all lanes
normalized to their corresponding loading control (Beta actin). Relative
phosphorylation was determined by also normalizing each phospho-epitope to its
respective total antibody expression. For example, after being normalized to
loading control, GSK-3J3 phospho-serine 9 values were also normalized to total
GSK-3J3. All treatment wells were normalized to controls and one-way ANOVA
with Dunnette's post-hoc test was used to determine differences in protein
expression between control and annonacin treated cells. P-values < 0.05 were
considered to be significant.
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CHAPTER III
RESULTS

Extraction and isolation of annonacin from Asimina triloba fruit pulp

Extraction and Isolation. TLC, FTMS, 1H_ and 13C-NMR, FTIR
spectroscopic analyses and polarimetry (optical rotation) revealed the presence
of annonacin in extracts isolated from pawpaw fruit pulp. When examined by
TLC in multiple solvent systems, isolated annonacin co-spotted with the An.
muricata sample (Figure 8). FTMS and NMR spectra corresponded with that of

the annonacin sample (Figures 9-10), and NMR shifts were consistent with
those previously reported for synthetic annonacin 90 (Table 3).

(5S)-5-Methyl-3-[(2R,8R, 13R)-2,8, 13-trihydroxy-13-[(2R,5R)-5-[(1 R)-1hydroxytridecyl]-2-tetrahydrofuranyl] tridecyl]-5H-furan-2-one. Annonacin:

R,= 0.35. HRMS calculated for C3sH6407 m/z [m + Nat: 619.4543; Found:
619.4546

±

0.6 ppm. 1H NMR 0 (400MHz, CDCb): 7.18 (s, 1H), 5.06 (q,

J=6.8Hz, 1H), 3.85 (m, 1H), 3.81 (dt, J=6.8Hz, 12Hz, 2H), 3.59 (m, 1H), 3.41 (dt,
J=6.8Hz, 12Hz, 2H), 2.52 (d, J=14Hz, 1H), 2.40 (dd, J=15.2Hz, 8Hz, 1H), 2.06
(m, 4 OH), 1.98 (m, 2H), 1.65 (m, 2H), 1.62-1.25 (m, 40H), 1.43 (d, J=6.8Hz),
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0.88 (t, J=6.8Hz, 3H); 13C NMR (400MHz, CDCI 3) <5: 174.51, 151.85, 131.14,
82.66,82.58,77.98,74.08,73.97,71.72,69.88, 37.32, 37.25, 33.42, 33.35,
31.90,29.70,29.65-29.62 signal overlap, 29.44, 29.33, 28.74, 25.63,25.57,
25.47,22.66,19.08,14.09. FTIR 3416,2922,2852,1744,1075 cm- 1. [a]020:
+20.4° (c=0.51, CHCb).
Isolation Optimization. The extraction and isolation process described

here represents a high-yield, reliable method for both preparing and purifying
extracts of the acetogenins from frozen fruit pulp and isolating annonacin. The
aforementioned procedure yielded pure annonacin (-90%) as determined by
HRMS (FTMS), high-field NMR, FTIR and optical rotation. The fruit of the
Eastern pawpaw tree, As. tri/oba is commercially available from health food
stores or local farms (See Materials and Methods). A kilogram of the raw peeled
fruit or commercially available frozen pulp may be conveniently processed on a
laboratory scale using a blender. Although extracting freeze-dried pulp with
organic solvents was considered for the initial stages of the process, the solventsolvent extraction of filtered homogenate derived from fresh or frozen pulp was
the best expedient in terms of time and mass transfer. Although classed as a
lipid, annonacin possesses four hydroxyl groups and is relatively polar as
compared to many other classes of small-molecule lipids. When choosing
solvents for the extraction-partitioning steps, methanol and ethyl acetate,
respectively, were found to be optimal and the sequence repeatedly delivered
-500 mg of crude extract per kilogram of pulp. On initial concentration of the
crude syrupy extract, a granular white water-soluble/ethyl acetate insoluble
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precipitate was observed, which was presumably the carbohydrate portion of the
extract and easily removed by vacuum filtration. At first a portion of the crude
isolate was submitted to flash chromatography (F-C) 102 on silica gel using
combinations of chloroform-methanol, since the chloroform methanol system was
optimal for separation of the suspected acetogenin components on analytical
TLC. However, the F-C system was not optimal since many of the less-polar
compounds, presumably terpenes or terpene-like compounds were carried
through before separation was effected. The most effective separation system
was a gravity silica gel column which utilized combinations of hexanes/ethyl
acetate and ethyl acetate/methanol with gradually increasing polarity of the
solvent mixtures. While previous work on natural products bearing the butenolide
(a,~

-unsaturated-Y-Iactone) subunit utilized the two-step Kedde reagent for

detection during chromatography, 103 the o-anisaldehyde TLC stain for the
individual fractions was the best expedient. While the Kedde reagent system
confirmed the presence of the desired acetogenin, the o-anisaldehyde TLC stain
was superior in terms of time and sensitivity for routine separations. Separation
and 1H NMR (500MHz) analysis of the intermediate fractions eluted with the ethyl
acetate/methanol solvent sequence revealed the presence of annonacin on
comparison with spectral data published by Wu and co-workers through their
enantioselective total synthesis of annonacin.
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Figure 8. TLC of annonacin isolated from Asimina triloba co-spotted with an

annonacin sample from Annona muricata. TLC mobile phase:
chloroform/methanol (9:1), stained with anisaldehyde and Kedde reagent. R,=
0.35. ANs MP

=annonacin sample derived from An. muricata, AN pp-EX =pure

annoncin isolated from As. triloba fruit.
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Figure 9. Fourier transform mass spectrometry (FTMS) spectra of crude ethyl
acetate extracts of As. tri/oba fruit pulp (cEX) reveals presence of annonacin
among other acetogenins (A). Spectra of annonacin-containing fractions after
the second (8) and third (C) chromatographic runs. Spectra of annonacin
sample derived from An. muricata (0). Comparison of As. triloba isolated
annonacin (E) with the An. muricata sample (F) showing a more narrow range of
spectra surrounding the annonacin peaks from C and

o.

High Resolution Mass

Spectrometry (HRMS) calculated for annonacin, C3sH6407mlz [m + Nat

619.4543; Found: 619.4546

±

0.5 ppm.
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1H NMR of annonacin
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Figure 10. Proton nuclear magnetic resonance CH NMR) spectra of annonacin from As. triloba fruit pulp (A) and

An. muricata (8). Spectra obtained with VNMRS 400MHz instrument using CDCb as solvent and internal standard .

Table 3. Chemical structures and 1H and

13C

NMR Data for Annonacin (R=H)

and Annonacin Tetraacetate (R=Ac)
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OR
31
32

R=H , 1H assignment

11 10 9

R=H, l :iC assignment

R=Ac. 'H assignment

C-2: 131 .2
C-3: 33.3

13

C assignment

C-l : 173.4

C-l : 174.7
H-3a: dd, 2.40 (15.2, 8.0)

R=Ac,

C-2: 130.1
H-3a: dd, 2.52 (14.4, 4.0)

C-3: 30.8

H-3b: dd, 2.52 (14.4, 4.0)

H-3b: dd, 2.52 (15.2, 8.0)
H-4: m, 3.85

C-4: 69.9

H-4: m, 4 .80-5.02

H-5-H-9: m, 1.25-1 .62

C-5-C-9: 22.7-37.3

H-5-H-9: m, 1.25-1 .40

C-4: 71 .8
C-5-C-9: 22.6-34.0

H-l0: m, 3.59

C-l0: 71.7

H-l0: m, 4.80-5.02

C-l0: 74.0

H-ll-H-14: m, 1.25-1 .62

C-ll-C-14: 22.7-37.3

H-l1-H-14: m, 1.25-1 .40

C-ll-C-1 4: 22.6-34.0

H-15: dt, 3.41 (12.0, 6.8)

C-15: 74.0

H-15: m, 4.80-5.02

C-15: 74.7

H-16: m, 3.81

C-16: 82.7

H-16: m, 3.97

C-16: 79.4

H-17: m, 1.65/ m, 1.98

C-17: 28.8/29.7

H-17: m, l .73/m, 1.94

C-17: 28.0

H-18: m, 1.65/ m, 1.98

C-1 8: 28.8/29.7

H-1 8: m, l .73/m, 1.94

C-18: 28.0

H-19: m, 3.81

C-19: 82.7

H-19: m, 3.97

C-19: 79.5

H-20: dt, 3.41 (12.0, 6.8)

C-20: 74.1

H-20: m, 4.80-5.02

C-20: 74.9

H-21-H-31 : m, 1.25-1 .62

C-21-C-31: 22.7-37.3

H-21-H-31 : m, 1.25-1.40

C-21-C-31 : 22.6-34.0

H-32: t, 0.88 (6.8)

C-32: 14.1

H-32: t, 0.88 (7.0)

C-32: 14.1

H-33: d, 7.18 (1 .4)

C-33: 151 .9

H-33: d, 7.09 (1 .5)

C-33: 151 .9

H-34: qd, 5.06 (6.8, 1.4)

C-34: 78.0

H-34: qd, 5.09 (7.0,1.5)

C-34: 77.5

H-35: d, 1.40 (6.8)

C-35: 19.1

H-35: d, 1.40 (7.0)

C-35: 18.9
C=O (Ac): 170.6; 170.8; 170.9

CH 3 (Ac): 5 , 2.03; 5, 2.04; 5, 2.07

CH3 (Ac): 21 .1-21 .2

Isolated and purified materials were dried and dissolved in CDCb (chemical shifts

o in ppm ; coupling constants J in Hz; 100 and 400 MHz),

Arrows highlight

positions where assignments differ between isolated and acetylated annonacin,
confirming the presence of reactive hydroxyl groups_
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Annonacin tetraacetate. The derivatization of polyol natural products by
conversion to the less polar acetate or even benzoate ester is a common practice
which facilitates smooth chromatographic purification of the parent compound or
may provide additional data for its thorough characterization. 104, 105 106 Crude
annonacin was treated with acetic anhydride and pyridine (4Bh/rt) producing the
chromatographically more mobile and solvent-soluble annonacin tetra acetate
(Figure 11) after purification by silica gel column chromatography (40.2 mg,
40%). TLC revealed complete consumption of the starting material (Figure 12)
and increased silica gel mobility. The tetra acetate was characterized and
confirmed by HRMS, 1H, 13C NMR, FTIR, and optical rotation (Figures 13--15).
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Figure 11. Conversion of annonacin to the tetraacetate derivative.
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Figure 12. TLC of annonacin co-spotted with the annonacin tetra acetate
derivative shows complete consumption of starting material and evidence of
increased mobility on silica gel of the tetraacetate . TLC mobile phase :
chloroform/methanol (9:1) and hexane/ethyl acetate (1: 1), stained with
anisaldehyde. AN pp-EX = pure annoncin isolated from As. triloba fruit, ANAc =
acetylated annonacin.
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(5S)-5-Methyl-3-[(2R,8R,13R)-2,8,13-triacetoxy-13-[(2R,5R)-5-[(1 R)-1acetoxytridecyl]-2-tetrahydrofuranyl] tridecyl]-5H-furan-2-one. Annonacin
tetraacetate: R,= 0.40. HRMS calculated for C43 H72 011 m/z [m + Nat:

787.4966. Found: 787.4963. 1H NMR (500 MHz, COCh) d: 7.09 (s, 1H), 5.10
(m, 1H), 5.01 (J=7Hz, 13.5Hz), 4.85 (m, 3H), 3.97 (m, 2H), 2.55 (q, J=4Hz,
14Hz), 2.52 (q, J=4Hz, 14Hz), 2.07 (s, 6H) signal overlap, 2.04 (s, 3H), 2.03 (s,
3H), 1.94 (m, 2H), 1.5-1.59 (m, 12H), 1.40 (d, J=6.5Hz), 1.25-1.4 (m, 30H), 0.88
(t, J=7Hz, 3H). 13C NMR (100 MHz, COCI 3) 0: 173.44, 170.87, 170.85, 170.59,
150.90,130.14,79.54,79.43,77.50,74.92,74.73, 74.00, 71.84, 34.01, 33.99,
31.87,30.82.30.75.29.84,29.62,29.65-29.59 signal overlap, 29.52, 29.44,
29.30,29.20,28.03,28.02,25.29,22.64,21.22, 21.10, 21.08, 18.89, 14.07.
[a]020 +7.45° (c=0.51 ,CHCh). FTIR 2927,2856, 1744, 1737, 1241 cm- 1.
The successful formation of annonacin tetraacetate provided additional
confirmation that our isolated material was annonacin as noted by shifts in
FTMS, NMR and FTIR absorptions where expected (Figures 13-15). Arrows in
Table 3 highlight where chemical shifts differ between annonacin and the

tetraacetate. These shifts confirm the conversion of hydroxyl groups to acetates,
as expected. Specifically the loss of OH bending in the FTIR tetraacetate
spectra indicated disappearance of the 4 hydroxyl groups that were evidenced by
a broad absorption band at 3416.74cm- 1 in the annonacin spectra. Furthermore,
the optical rotation ([a]020 = +20.4°) of our purified material corresponds to that of
annonacin prepared by stereoselective synthesis ([a]020 = +21),107 which confirms
that it possesses the same stereochemistry as annonacin.
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FTMS of annonacin and annonacin-tetraacetate
A

LP 154_3_AC FT MS #1 RT: 0.02 AV: 1 /l.L. 0<.",,'=8
T: FTMS + p ESI Full ms [50.00-1000.00)
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Figure 13. FTMS spectra for tetraacetate derivative of isolated annonacin (A).
Panel B shows a more narrow range of the spectra around the tetraacetate peak.
HRMS calculated for annonacin tetraacetate, C43H7201 1m/z [m + Nat 787.4966;
Found: 787.4963 ± 0.4 ppm.
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1H NMR of annonacin and annonacin-tetraacetate
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Figure 14. Comparing 1H NMR spectra for annonacin (A) and annonacin
tetra acetate (8) shows shift in peaks where expected. Spectra obtained with
VNMRS 400MHz instrument using CDCb as solvent and internal standard.
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FTIR of annonacin and annonacin-tetraacetate
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Figure 15. Fourier transform infrared (FTIR) spectra of annonacin isolated from
Asimina triloba: 3416.74cm- 1 = OH groups, 2922.2cm- 1 = CH 2's, 2852.19 cm- 1 =
THF ring, 1744.09cm-1

=butenolide (A) compared to spectra of the tetraacetate

derivative 2927.53 cm- 1 = CH2'S, 2856.29 cm-1= THF ring, 1737.72 cm- 1 =
acetates with butenolide shoulder (8). Note, as expected, in 8 there is no longer
a peak corresponding to the OH groups confirming complete consumption of
starting material and tetraacetate formation. Purified samples dissolved in CHCb
and spotted on salt plates for spectral acquisition using Perkin-Elmer Spectrum
100 instrument.
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Quantification. The amount of annonacin isolated per gram of frozen
fruit pulp was 0.07 ± 0.03 mg as determined by average weight from extractions
on 5 separate batches (Table 4). Based on repeated extractions it was
determined that annonacin represents 0.01 % of pawpaw pulp by weight
determination. On average, annonacin made up ten percent of the total crude
EtOAc extract (cEX). One additional extraction was done on locally harvested
fresh fruit, which gave an annonacin yield of 0.12 mg per gram of pulp.
Table 4. Annonacin content of Asimina triloba vs. Annona muricata
Average
total fruit
weight 1(g)

Amount
annonacin
per fruit
(mo)

-300
Asimina triloba
7.0
Frozen fruit
pulp
Fresh fruit pulp3
12.3
-800
15.0
Annona
muricata
1Note these values reflect weight of the whole

Amount
annonacin per
gram of fruit
pulp2 (mo/o)

0.07
0.12
0.02
fruit (Le. including

skin, seeds and pulp). 2The amount of annonacin per gram of fruit
pulp is based on the amount of pulp used in the extraction, not the
weight of the whole fruit. 1o 3Quantities in fresh fruit are based on
data from one extraction; one pawpaw fruit yielded 100 grams of
pulp on average.
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In vitro toxicity of annonacin and Asimina triloba organic fruit extract

Annonacin treatment reduced the number of viable cells remaining in the
culture 48 hours after treatment at concentrations as low as 10

~M

(p < 0.001,

Figure 16) as determined by MTT assay. Immunocytochemistry confirmed
neuronal toxicity as shown by a decrease in MAP2 immunoreactivity and
changes in neuronal morphology indicative of neurodegeneration, prior to cell
death (Figure 17). Similar to MAP2 staining, images reveal an overall decrease
in total tau (DA9) immunoreactivity in response to annonacin treatment (Figure
18) confirming annonacin toxicity in neuronal cells.
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Cortical neurons 48hrs after treatment

~ pure [AN]

•

rotenone

***

':P
Dose (tAM)

Figure 16. MTT assay of cortical neurons 48 hours after treatment with purified
annonacin isolated from Asimina triloba fruit pulp. LD50 for annonacin

=50.45

IJM (i.e. ) ± 1.07. Bars represent mean (± SEM) viability relative to vehicle
control-treated cultures. Diagonal lines = annonacin (IJM). checkered fill =
rotenone (IJM), p-value < 0.001 (***).
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Time-response of MAP2 immunoreactivity in cortical neurons after annonacin treatment

vc

8h

~

24 h

48 h

AN

ROT

Figure 17. Cells were fixed as noted in the text at 8,24, and 48 hours after
treatment and visualized with anti-MAP2 immunotstaining (red). Nuclear
chromatin was co-stained with Hoechst (blue). Merged images are shown. VC

=

vehicle (DMSO) control; AN = 75IJM annonacin; ROT = 1 IJM rotenone. A
decrease in MAP2 immunoreactivity in response to annonacin treatment confirms
neuronal toxicity. All images taken with 20x objective; scale bar
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=100 IJm.

Tau immunoreactivity in cortical neurons after annonacin treatment

Hoechst

DA9Tau
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Merge

Figure 18. Cells were fixed as noted in the text at 8 and 24 hours after treatment

with either 75 ~M annonacin (AN) or 1 ~M rotenone (ROT). Immunostaining with
anti-total tau antibody OA9 (green) suggests an overall reduction in tau in
response to annonacin treatment. Nuclear chromatin was co-stained with
Hoechst (blue). VC

=vehicle (OMSO) control.

objective; scale bar

=50 ~m.
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All images taken with 20x

During initial treatments with cEX, an oily precipitate was noticeable in the
culture media, indicating that cEX was not completely dissolving and therefore
likely not reaching the cells to have an effect. Therefore, experiments were
conducted to determine the most appropriate solvent for cEX that would also be
tolerated by the cultured neurons. Data showed that EtOAc was well tolerated by
the cells (Figure 19). As expected considering the extract procurement process,
EtOAc was also the most effective of the solvents considered (DMSO, MeOH,
EtOH, EtOAc) at dissolving cEX. ACG-free treatment did not result in cell death
indicating that the processing of extract components per se is not sufficient for
procuring toxic material (Figure 20). The LD50 values for purified annonacin and
cEX 48 hours after treatment were 30.07 ~g/ml (Le. 50.45 ~M) and (47.96 ~g/ml)
respectively, as determined by non-linear regression analysis of MTT viability
data. Comparison of LD50 values between pure annonacin and the amount of
annonacin present in cEX (LD50

=4.80 ~g/ml) confirmed that cEX has more toxic

potential than annonacin by itself (p < 0.0001, Figure 21). Though the lack of
significant difference between pure annonacin and total cEX suggest that the
presence of other compounds in cEX may affect annonacin toxicity.
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Figure 19. Relative viability of primary cortical neurons 48 hours after treatment with one of
three solvents (MeOH, EtOH, and EtOAc) as determined by MTT assay. Values for each
solvent were normalized to the standard DMSO control. EtOAc consistently resulted in high
levels of viability compared to DMSO treated controls. Due to the dramatic difference in relative
viabilities between solvent groups, MeOH and EtOH relative viabilities are plotted on left Y-axis
whereas EtOAc relative viability is plotted on right Y-axis. X-axis is the amount of solvent added
(Le. 0.5-2.5 IJI) per well on a 96-well plate (total volume = 200 IJI' well). Rotenone treatments
were included as positive controls for achieving toxicity in each solvent. ROTs
added in respective solvent but normalized to DMSO control. ROTsn

=1 IJM rotenone

=1 IJM rotenone added in

respective solvent and normalized to respective solvent. 1IJM ROT = 1 IJM rotenone added in
DMSO and normalized to DMSO. Bars represent average of wells from one (MeOH and EtOH)
or three (EtOAc) independent experiments. Error bars = SEM. Numbers above columns are
the actual values of relative viability for the respective treatment.
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Cortical neurons 48hrs after pawpaw extract treatments
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Figure 20. Relative viability of cEX (crude, red bars) was significantly lower at
each dose than ACG-free (plaid bars) treatment p < 0.0001 (****). All doses of
cEX significantly reduced cell viability compared to vehicle-treated controls (p <
0.001). ACG-free treatment only significantly reduced viability at high
concentrations (Le. ~ 500 !-Ig/ml, p < 0.01). Bars represent relative viability,
normalized to controls (mean ± SEM). P-values determined by one-way ANOVA
with Dunnett's post hoc comparison.
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Dose-responses of cortical neurons 48hrs after
pawpaw extract treatments

-1

o

1

2

3

Log(Dose) Jl9/ml
Figure 21. Dose-response curves for cEX (crude, red line, LD50 = 47.96 jJg/ml)
and for pure annonacin (jJg/ml) (solid blue line) compared to amount of
annonacin (jJg/ml) in the crude extracts (dashed blue line) 48 hours posttreatment. LD50 of pure annonacin alone (30.07 jJg/ml , i.e. 50.45 jJM ) is
significantly higher than that of annonacin in the presence of crude extracts (4.80
!-Ig/ml , p < 0.0001 (****)). LD50 values determined by nonlinear regression of
log (dose) v. relative viability. Gray dashed lines represent 95% confidence
intervals for dose-response data.
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In vitro effects of annonacin on microtubule associated protein tau

Considering the changes in neuronal morphology noted above by MAP2
and tau staining, the effect of annonacin on tau in cortical neurons was assessed
at early time-points. To further assess annonacin's effect on tau, Western
blotting was utilized to determine changes in the levels of tau expression 4 hours
after treatment (Figure 22). Contrary to previous reports,37 but consistent with
the above noted patterns of tau-immunostaining, annonacin resulted in a
decrease in total tau (DA9, p < 0.01). Statistical analysis of western blot data
revealed that neither annonacin nor rotenone resulted in any changes in tau
phosphorylation. Originally it was hypothesized that annonacin would induce tau
phosphorylation. Since GSK-3J3 is known to phosphorylate tau, it was also
hypothesized that annonacin treatment would activate GSK-3J3, therefore
western blot analysis of total GSK-3J3 and GSK-3J3 phosphorylated at serine 9
(inactive form) was performed. In contrast to the initial hypothesis but consistent
with the above noted changes in tau, annonacin did not induce any changes in
GSK-3J3 expression (Figure 23).
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Tau expression 4 hrs. after annonacin treatment
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ROT

Figure 22. Western blot analysis of tau protein expression was performed as
described in the text. J3-actin was used as loading control. Lysates from 4
different experiments were run on the same blot (A) with letters A-D representing
a different experiment. In A, lanes 1-5 are VC, VC, AN, AN, R. In B lanes 1-3
are VC, AN, R. In C, lanes1-3 are VC, VC, AN. In 0, lanes 1-2 are VC, AN. VC

=vehicle (DMSO) control, AN =75 IJM annonacin, ROT =1 IJM rotenone.
Quantitative analysis of relative abundance is graphically represented in panel B.
One-way analysis of variance (ANOVA) with Dunnett's post-hoc test revealed a
significant decrease in the amount of total tau (DA9, p-value = 0.01 (*)) 4 hours
after annonacin treatment. Bars represent relative expression from 4
independent experiments (mean ± SEM) as determined by normalizing
absorbance values for each blot to its respective beta-actin blot and then to
vehicle control. Phospho-tau epitopes were also normalized to total tau in order
to determine relative phosphorylation. Diagonal lines
PHF-1, diamond

=MC-1, horizontal lines =CP-13.
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=DA 9, small checks =

GSK-313 expression 4 hrs. after annonacin treatment
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Figure 23. Western blot analysis of GSK-3J3 expression was performed as
described in the text. J3-actin was used as loading control. Lysates from 4
different experiments were run on the same blot (A) with letters A-D representing
a different experiment. In A, lanes 1-5 are ve,
are

ve, AN, R.

In

ve, AN, AN, R.

e, lanes1-3 are ve, ve, AN.

In B lanes 1-3

In 0, lanes 1-2 are

ve, AN. ve

=vehicle (DMSO) control, AN =75 j..IM annonacin, ROT =1 j..IM rotenone.
Quantitative analysis of relative abundance is graphically represented in panel B.

One-way analysis of variance (ANOVA) with Dunnett's post-hoc test revealed no
significant changes in GSK-3J3 expression 4 hours after annonacin treatment.
Bars represent relative expression from 4 independent experiments (mean ±
SEM) as determined by normalizing absorbance values for each blot to its
respective beta-actin blot and then to vehicle control. Phosphorylation of GSK-

3J3 on serine 9 was determined by additional normalization to total GSK-3J3.
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CHAPTER IV
DISCUSSION

Extraction and isolation of annonacin from Asimina tri/oba fruit pulp
The above results have (1) revealed the presence of annonacin in fruit
pulp of the annonaceous tree, Asimina triloba, and (2) determined the amount of
annonacin per gram of pulp. The presence of annonacin in fresh and frozen
pawpaw fruit was verified by chromatographic and spectroscopic techniques.
The extraction, isolation and chromatographic purification of annonacin from
pawpaw fruit described herein is an effective method for procuring the material in
suitable enough quantities so that both biological and chemical studies may be
conducted. The fresh or frozen fruit is readily available in large quantities and
the maceration/liquid-liquid partitioning protocol is time-effective and precludes
the use and expense of freeze-drying equipment. Based on repeated extractions
it was determined that annonacin represents 0.01 % of pawpaw pulp by weight
determination. This is higher in comparison to other sources of annonacin:
0.0004% Annona cherimolia seeds 107 and 0.002% Annona muricata (soursop)
pulp;1o presenting pawpaw fruit pulp as a new, easily accessible source of
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biomass for isolating substantial amounts of annonacin for use in biological
studies.
The first stereoselective synthesis of annonacin involved multiple (24+)
steps and yielded similar quantities of annonacin. 9o A shorter synthetic route to
annonacin was recently reported; 108 however, this technique still involved
multiple steps (14+) and may not be optimal for obtaining large quantities.
Therefore, the isolation technique reported here proved to be more efficient than
original synthetic strategies for procuring annonacin in quantities suitable for
small scale biological studies. Nevertheless, while natural product isolation is
useful for small scale studies, development of a novel synthetic strategy with
minimal steps is necessary to routinely procure quantities large enough to
maintain multiple, ongoing biological studies.
The high concentration of annonacin in pawpaw pulp reported here is
significant considering the neurotoxicity reported by Champy and colleagues in
annonacin treated rats,5 which suggest that regular consumption of the
annonaceous fruit, soursop, could lead to neurodegeneration. Specifically, Dr.
Champy's results indicate that the amount of annonacin present in one soursop
fruit is high enough such that regular consumption (i.e. one fruit per day per year)
could lead to neurodegeneration. 1o This is consistent with epidemiological
reports of increased overall lifetime consumption of annonaceous products in
atypical parkinsonian cases (2g/kg) compared to controls (O.5g/kg).40 Therefore,
one would need to consume on average approximately 1 soursop fruit per day for
25.6 years to reach the aforementioned overall level of consumption. This same
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level of annonacin intake could be reached in 27.3 years by consuming an
average of approximately 10 pawpaw fruits per day for 90 days per year
(according to annual availability of ripe fruit). Though this is substantially more
fruit to consume in one day, it is plausible considering the relatively small size of
each pawpaw compared to soursop (100 versus 750 g of pulp, respectively).
Fresh pawpaw is less likely to be consumed year-round, hence the difference in
the number of days consumed per year between the 2 fruits. However, due to
the increasing popularity of pawpaw, fruit products (e.g. frozen fruit pulp) are
available for online purchase year-round, allowing for more regular consumption
and in turn requiring fewer fruits per day and/or a shorter time period to reach the
same amount of overall life-time consumption. Therefore, it is feasible for one to
ingest high enough levels of annonacin by regularly consuming pawpaw fruit.
Due to its lipophilic nature,63 it is reasonable to assume that annonacin
can cross biological membranes and interact with intracellular components.
Champy and colleagues demonstrated that annonacin can cross the blood brain
barrier after intravenous administration. 5 Though this supports the hypothesis
that annonacin could reach the brain after fruit consumption, it should be noted
that the potentially toxic exposure levels discussed above are assumptions
based on animal studies. Some studies have shown that intraperitoneal injection
of acetogenins or oral consumption of crude pawpaw extract inhibits tumor
growth and delay tumor genesis. 42 ,109-111 Though these studies did not evaluate
post-mortem tissue for the presence of acetogenins, the antiCipated outcome of
cancer cell death suggests the ability of these compounds to reach cellular
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targets. Contrarily, rats orally consuming pawpaw extract showed no trace of
acetogenins in their blood via LC-MS/MS analysis even though the treated rats
showed a delay in tumor growth compared to untreated controls. 11 Considering
these limited and conflicting reports, there is a need for detailed pharmacological
studies to accurately determine the bioavailability of annonacin and other
acetogenins after oral ingestion in order to truly evaluate the risk of fruit or extract
consumption.

In vitro toxicity of annonacin and Asimina triloba organic fruit extract
Acute annonacin treatment was toxic to cortical neurons (PO) at low
micromolar concentrations while treatment with the ACG-free extract did not
affect neuronal viability, indicating that the neurotoxicity of annonacin was not an
artifact of the extraction process. Furthermore, annonacin was more toxic in the
presence of cEX than when purified in terms of the amount of annonacin present
in each treatment, suggesting that multiple acetogenins synergistically affect
neuronal viability. The presence of bis-tetrahydrofuranyl acetogenins such as
bullatacin was likely contributing to the neurotoxicity of cEX

1,63

On the other

hand, cEX as a whole was not more potent than purified annonacin, exemplifying
the complexity of interactions between numerous similar compounds and their
cellular target(s). It is possible that the toxicity of cEX was primarily due to
another acetogenin, such as bullatacin, which itself could be more toxic than
annonacin. This would explain the difference in LDso values between purified
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annonacin and annonacin in the presence of cEX. Nonetheless, a synergistic
effect of multiple acetogenins, including annonacin, cannot be ruled out since all
acetogenins may share the same binding site. 109 The difference in solvents used
as the vehicle between cEX and annonacin treatments could explain why cEX
was not wholly more toxic than annonacin alone since the cultures were more
tolerable of EtOAc than DSMO. However, it is unlikely that there was a
protective effect of EtOAc since it did not prevent rotenone toxicity.
Annonacin was less potent in cortical neurons than previously reported in
mesencephalic and striatal neurons. 37,63 Cortical neurons were utilized for
toxicity experiments not only because they are generally less sensitive to insult
than mesencephalic cultures,112 but primarily because they are affected in
various neurodegenerative diseases. 45 , 46, 69 Annonacin, among other
acetogenins, has been shown to inhibit mitochondrial complex-1 ,3, 34, 37, 63,109,113
which is vital for the production of A TP and a key target of oxidative stress due to
the generation of reactive oxygen species (ROS). Furthermore, mitochondria act
as calcium stores that help regulate the levels of intracellular calcium, which must
be tightly controlled in order to maintain normal neuronal functioning. While
increased oxidative stress may be detrimental to all neuronal types, substantia
nigra neurons may be particularly vulnerable due to physiological properties
distinct to their dopaminergic phenotype. For example, the catabolism of
dopamine by monoamine oxidase results in the generation of ROS, adding to the
oxidative burden of these cells. 114 Moreover, the intrinsic pace-making activity of
midbrain neurons may render them more susceptible to calcium excitotoxicity
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and increase the energy demand in order to maintain intracellular calcium
homeostasis. 115 Midbrain neurons are also much larger than cortical neurons
with many more afferent synapses and corresponding energy requirements. 116
These increases in the need for ATP production result in the generation of even
more ROS making the DA cell even more vulnerable to oxidative stress and ATP
depletion. Additionally, annonacin has recently been shown to cause an
increase in intracellular calcium,117 which may be more detrimental to calciumsensitive dopaminergic cells than to cortical neurons. Together these factors
may contribute to the increased vulnerability of dopaminergic neurons to
mitochondrial toxins and explain the differences between the annonacin potency
reported here and in previous studies. 115,118
The important experimental difference of cell origins may also explain
why, contrary to previous reports of annonacin sharing similar potency with
rotenone,56,63 rotenone was found to be more potent than annonacin in this
model. Alternatively, one can speculate that the greater toxicity of rotenone may
be due to its potential interactions with cellular targets other than mitochondrial
complex-1, such as c-JUN N-terminal protein kinase (JNK), p38 mitogen
activated protein kinases, phosphatase 2 B (calcineurin), and GSK3~, among
others. 82,89,92,96,112 For example, Choi and colleagues have shown that the
neurotoxicity of rotenone is not dependent upon its ability to inhibit complex-1. 82
Additionally, it has been proposed that rotenone may bind at a different site of
complex-1 than annonaceous acetogenins, which could account for differences
in potencies. 2, 80 The combination of the increased sensitivity of midbrain
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neurons to oxidative stress and the ability of rotenone to act via other
mechanisms could explain the descrepancies between annonacin potency here
and prior reports as well as between annonacin and rotenone in this modeI.82.118121

It was previously determined that, following the cell culture protocol
described above in Chapter 11,80% or more of cells in the culture are neurons
(unpublished data). Additionally, Ara-C was added to the cultures in order to
inhibit the proliferation of non-neuronal cells; therefore, the reported toxicity was
likely due to the loss of neuronal cells in the culture. Indeed,
immunocytochemistry showed reduced MAP2 immunoreactivity in annonacintreated cultures after 48 hours, indicating toxicity to neuronal cells as MAP2 is a
neuron-specific marker. To date, As. triloba toxicity has only been evidenced in
cancer cell lines, and roughly addressed in cancerous murine models. 8 This
finding of in vitro cortical neurotoxicity corroborates previous reports of annonacin
neurotoxicity to nigral neurons 5. 37. 55. 56 broadening the significance of
annonacin-induced toxicity as it relates to neurodegeneration. The neurotoxiCity
results are particularly interesting considering the cortical neurodegeneration
seen in a number of diseases including AD, FTD and corticobasal
degeneration.46. 48. 52. 69
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In vitro effects of annonacin on microtubule associated protein tau
The microtubule associated protein tau plays a number of important roles
involved in maintaining proper neuronal morphology and function. 122 Tau is
particularly important for regulating microtubule (MT) dynamics, which is crucial
for neuronal viability. The ability of tau to interact with microtubules is affected by
its phosphorylation status, with hyperphosphorylation resulting in a decreased
affinity for MTs.123-126 Likewise, tau may be involved in MT stability and dynamic
instability with its specific action depending on the isoform, therefore the ratio of
3R to 4R tau is also vital for neuronal functioning. 127 , 128
Annonacin treatment of cortical neurons resulted in decreased levels of
total tau (DA9). The annonacin induced decrease in tau protein expression is
interesting as it was previously shown to cause an increase in both phospho- and
total tau; however, this was attributed to a decrease in tau degradation rather
than increased expression since tau messenger ribonucleic acid (mRNA) was
decreased after annonacin treatment. 37 The finding of decreased tau expression
in conjunction with annonacin neurotoxicity is also interesting considering the
ongoing debate regarding the role of tau in neurodegenerative pathogenesis.
While the association of tau aggregation with neurotoxicity has been
demonstrated,127, 129-131 others propose that the formation of tau aggregates is
the cells attempt to protect itself from toxic, soluble tau species. 132, 133 Likewise,
though hyperphosphorylation of tau is undoubtedly an important factor
contributing to neuronal dysfunction in tauopathy, the mechanism by which this is
explained remains a topic of debate. Some suggest tau hyperphosphorylation
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may result in a loss of normal functioning due to an inability to properly bind and
regulate microtubules.134-136 The observation that paclitaxel, a microtubule
stabilizing agent, prevented tau-mediated toxicity supports this hypothesis. 137
Contrarily, others show not only is there a lack of evident neurodegeneration or
neuronal impairment in tau knockout studies, but suggest that reducing tau may
be neuroprotective122, 138 (and references therein). On the other hand, some
studies suggest that tau abnormalities, and hence microtubule dysfunction, may
disrupt mitochondria leading to oxidative stress and cell death. 83 , 129, 133 As this
project was intended to evaluate the effect of annonacin on tau phosphorylation,
the precise mechanistic and temporal relationships between tau reduction and
cell death cannot be concluded. However, this finding supports the tau "loss of
function" hypothesis, and the early time-point (4 hours) suggests the loss of tau
occurs early in the process of annonacin neurotoxicity.
Though it is plausible that the neurotoxic effects of annonacin
demonstrated here may be a result of direct action on tau andl or microtubules,
this explanation is unlikely as it was previously shown that annonacin toxicity
persisted in the presence of taxol, which stabilized microtubules and prevented
the somatic redistribution of tau.

37

This suggests that annonacin is not directly

impairing microtubules or causing a toxic loss of function in tau. Alternatively, the
noticeable changes in tau could be a downstream effect of annonacin induced
complex-1 inhibition, as previously reported. 5, 37, 56, 63 In support of this
mechanism of action is the observation that mitochondrial inhibition and oxidative
stress effects tau phosphorylation and reports of impaired mitochondrial
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dynamics leading to neurodegeneration 137,139,140 (and references therein).
Fluorescent-labeled synthetic acetogenins have been shown to localize in
mitochondria,141 further supporting a direct effect on complex-1 with changes in
tau being secondary. Certainly, tau is an important protein for proper neuronal
functioning and its dysregulation could be detrimental to the cell; however, the
results presented here cannot determine whether the decrease in tau is a cause
or consequence of impaired neuronal functioning.
At the outset of this project, it was hypothesized that annonacin would
result in increased tau phosphorylation; therefore, its effect on GSK313 was
considered due its ability to phosphorylate tau at a number of biologically
relevant sites and implication in tau pathology.87-89 As expected based on its
effects on tau, annonacin did not induce a significant change in total or phospho-

GSK313 expression. Though not in support of the initial hypothesis, this finding
does support the hypothesis that any annonacin-induced changes in tau are
likely secondary to complex-1 inhibition.
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CHAPTER V

STRENGTHS AND LIMITATIONS

Theugh variability in fruit ripeness was net considered, this project
capitalized en the availability ef As. triloba fruit pulp as it is typically censumed
(Le. ripe fruit er cemmercially supplied frezen fruit pulp), and utilized efficient
extractien and iselatien metheds aleng with multiple analytical techniques to.
determine the presence and quantificatien ef annenacin. While this methed ef
precuring annenacin was efficient fer the purpeses ef this study, the develepment
ef a nevel, large-scale synthesis sheuld be empleyed fer ebtaining quantities
suitable fer maintaining multiple, engeing bielegical testing. In addition to. the
petential difficulties in acquiring large ameunts ef biemass fer acetegenin
extractien and annenacin iselatien, anether limitatien to. precurement via natural
preduct iselatien is the variability ef quality and quantity ef the final product. A
new synthetic strategy weuld previde fer a mere standardized precess fer
ebtaining censistent ameunts ef pure material.
This study revealed the presence ef annenacin in As. triloba fruit pulp and
substantiated the neuretexicity ef annenacin as well as the crude, acetegenincentaining extract in a different medel system than previeus studies. The crude,
acetegenin-centaining extract mere clesely represents the cempesitien ef actual
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consumed fruit and plant products. Hence, the finding of cEX neurotoxicity
suggests a synergistic effect among acetogenins and provides insight into the
neurotoxic potential of the fruit, which is important when considering potential
deleterious effects of using As. triloba products chronically for the treatment of
cancer.
The in vitro, acute treatment design of this project precludes any
conclusions regarding chronic, in vivo toxicity; however, the use of primary
neuronal cultures provides a reliable system for elucidating potential mechanisms
of action occurring at the cellular level that should be investigated further.
Additionally, the use of cortical neurons expands upon the current annonacin
literature, which, with regard to neurotoxicity, has previously been confined to
mesencephalic and striatal cultures. Likewise, although nothing can be
concluded regarding bioavailability of orally consumed fruit from this study, it was
previously demonstrated that annonacin crosses the blood brain barrier,5, 6
therefore the neurotoxic effects of annonacin noted here could be exerted in vivo
as well. As this project was designed to confirm previous findings of annonacin
induced tau pathology; various other potential mechanisms of action and the
mode of tau pathology were not considered. Considering the discrepancies
found here with previous reports of annoancin's effect on tau, re-examination of
its other noted effects (i.e. complex-1 inhibition) may be warranted to confirm
prior assumptions of its mechanism of action. Additionally, while this is the first
report of an annonacin-tetraacetate derivative, this project did not explore the
effects of annonacin acetylation or other structural modifications on its
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neurotoxicity, which may provide valuable insight into its specific binding sites on
cellular targets.
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CHAPTER VI

CONCLUSIONS AND FUTURE CONSIDERATIONS

In summary, these results established the presence of annonacin in As.
triloba fruit pulp, determined the cortical neurotoxicity of annonacin as well as
crude acetogenin-containing fruit extract, and revealed an early decrease in the
microtubule associated protein tau in response to annonacin treatment. These
findings corroborate previous reports of annonacin neurotoxicity

5, 37, 55, 56

and

broaden the potential relevance of annonacin to neurodegenerative diseases
with cortical pathology.
Consumption of Pawpaw in the United States could eventually be more
widespread than that of other annonaceous fruits considering As. triloba is the
only edible annonaceous fruit that is not confined to tropical areas, grows
throughout the Eastern United States, is available to consumers all year round
(e.g . frozen pulp, jam , etc.), is being pushed as an alternative cash-crop to
tobacco in some states, and is touted for its potential use in alternative medicine
with Paw-Paw Cell-Reg ™ (an annonacin-containing commercial supplement
made from pawpaw twig extracts). being marketed as beneficial for overall health
(www.naturessunshine.com) and as a safe complement to cancer
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therapy.8,

11,26,142

Therefore, future studies must corroborate the finding of As.

triloba fruit extract neurotoxicity discussed herein and elaborate on this and other
reports of annonacin induced tau pathology.
The two primary directions for the future of As. triloba implicated by the
findings presented here are 1) in vivo testing of chronic, oral fruit consumption to
determine the bioavailability and more closely mimic human exposure in order to
better understand the risks associated with consumption of annonaceous fruits,
and 2) further elucidating mechanisms of annonacin action and effects on tau in
order for it to be developed as a potentially novel model neurotoxin specific to
tauopathy.
Although not directly translatable to human consumption, when
considered with previous findings, the results reported here warrant further
investigation regarding the toxic potential of pawpaw fruit and tree products.
There are a few reports that acetogenin-containing pawpaw extract is safe and
tolerable after of oral ingestion as determined by changes in weight of mice and
beagle dogs; however these studies did not determine the presence of
acetogenins in specific tissues after consumption. 8,42 Champy and colleagues
have demonstrated the presence of annonacin in the cortices of rats after chronic
intravenous infusion. s Similar studies should be done after chronic oral ingestion
to determine if this translates risk to fruit consumption. Likewise, it would be
insightful for one or multiple studies employing the same methodologies of
administration and histological examination to consider both the therapeutic (i.e.
tumor growth inhibition or delay) and neurotoxic effects (i.e. midbrain, striatal and
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cortical cell loss and tau pathology) of long-term in vivo exposure to acetogenins
in order to truly model the risks/ benefits of these compounds. Pawpaw
consumption should also be included in epidemiological studies investigating risk
factors for neurodegeneration, and its use in alternative medicine further
scrutinized in order to resolve conflicting epidemiological reports.40, 143
The moderate lipophilicity of annonacin and other acetogenins likely
contributes to its ability to cross biological membranes, but may prevent it from
accessing intracellular targets that are not localized near the cell membrane.
While studies have suggested how the different acetogenin components (Le
tetrahydrofuran ring placement, number of hydroxyl groups, hydrocarbon chain
length, terminal lactone moiety) effect bioactivity, the majority of these have
focused on their effects on specificity and potencies in various cancer celilines. 1,
109,144-147 It would be interesting to note the effects of structural modifications on
acetogenin neurotoxicity. Utilizing fluorescently labeled annonaceous
acetogenins as probes, such as Kojima and colleagues have recently
synthesized, in combination with time-lapse imaging studies will be valuable in
further understanding the direct mechanism(s) of action of these compounds. 141
Recent studies have suggested that acetogenins may act as calcium
chelators, causing increased intracellular calcium and initiating cell death
mechanisms. 32 ,117 Maintaining calcium homeostasis is vital for neuronal
signaling, and its dysregulation may be directly involved in neurodegenerative
mechanisms.148-151 Considering this and its implications in the vulnerability of
substantia nigra neurons as noted in Chapter IV, future studies should elaborate
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on the potential for acetogenins to interact with calcium or calcium modulators as
a primary mechanism of action leading to impaired mitochondrial dynamics and
tau pathology.117, 144, 150 Similarly, in vivo neurophysiological recordings during
annonacin treatment could corroborate changes in neuronal calcium flux and
provide a better understanding of how annonacin is immediately influencing
neuronal activity.119 Ultimately, a better understanding of acetogenin
mechanisms and specificity could lead to development of a novel class of
neurotoxins for use in modeling specific diseases such as PSP and related
tauopathies or acetogenin derivatives that may be safe and useful in the
treatment of certain cancers.
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APPENDIX A:
LIST OF ABBREVIATIONS

3R

3 repeat

4R

4 repeat

ACG

acetogenin

ACS

American Chemical Society

AD

Alzheimer's disease

An.

Annona

AN

annonacin

AN-Ac

annonacin tetraacetate

ANOVA

analysis of variance

APD

atypical parkinsonian disorders

ANpp-Ex

pure annoncin isolated from As. triloba fruit.

As.

Asimina

ANsMP

annonacin sample derived from An. muricata

ATP

adenosine triphosphate

BBB

blood-brain barrier

BME

basal medium Eagle

c

cis
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CBD

cortical basal degeneration

CDCI2

deuterated dicholormethane

cEX

crude ethyl acetate extract

CP-13

anti-tau phosphorylated at serine 202

DA

dopamine

DA9

anti-total tau

diH20

deionized water

DIV

day in vitro

DMSO

dimethyl sulfoxide

EC

effective concentration

er

erythro

ESI

electrospray ionization

EtOAc

ethyl acetate

EtOH

ethanol

F-C

flash chromatography

FTDP-17

fronto-temporal dementia with parkinsonism associated with
chromosome 17

FTIR

Fourier-transform infrared spectroscopy

FTMS

Fourier transform mass spectroscopy

G.

Goniothalamus

GABA

v-aminobutyric acid

Gd

Guadeloupian

GSK-3p

glycogen synthase kinase

HRMS

High Resolution Mass Spectral

IC

inhibitory concentration
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JNK

c-JUN N-terminal protein kinase

LD

lethal dose

L-DOPA

L-3,4-dihydroxyphenylalanine

LTQ-FT

linear trap quadrupole-fourier transform

MAP

microtubule associate protein

MC-1

anti-tau conformational epitope (recognizes amino acids 7-9 and
326-333)

MeOH

methanol

MPTP

1-methyI4-phenyl 1,2,3,6-tetrahydropyridine

MPP+

1-methyl-4-phenylpyridinium

mRNA

messenger ribonucleic acid

MT

microtubule

MTT

3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide

NFT

neurofibrillary tangles

nM

nano-Molar

NMR

Nuclear magnetic resonance

OR

odds ratio

P.

Phaleria

PO

Parkinson's disease

PDC

Parkinson-dementia complex

POL

poly-D-Iysine

PHF

paired helical filament

PHF-1

anti-tau phosphorylated at serines 396 and 404

PSg

phosphorylated at serine 9

PSP

progressive supranuclear palsy
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PQ

paraquat

R.

Rollinia

ROS

reactive oxygen species

ROT,R

rotenone

rt

room temperature

SK-N-MC

human neuroblastoma cell line

t

trans

th

threo

TH

tyrosine hydroxylase

THF

tetrahydrofuran

TIQ

tetrahydroisoquinolone

TLC

thin layer chromatography

IJg

micro-gram

IJrn

micro-meter

IJM

micro-Molar

VC

vehicle control
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APPENDIXB:
EXTRACTION & ISOLATION PROTOCOL

Extraction of Asimina triloba fruit pulp:

1)

Weigh total amount of fruit pulp (thawed previously) to be extracted

2)

Homogenize pulp with MeOH
a) 700-800mL of MeOH/1kg of pulp
b) Record total final volume of all pulp/MeOH homogenate

3)
4)

Let homogenate steep overnight in fridge
Vacuum filter homogenate
a) Cut fast filter paper to fit filters, use 2 layers of filter paper/ funnel
b) Soak filter papers with MeOH before adding homogenate
c) Add 1/2 homogenate to each filter funnel
d) Filter until cake forms and wash with 50% MeOH (in diH20)
400mL 50%MeOH/800mL homogenate
e) Continue filtering until completely dry filter-cakes form
f) Record weight of filter cake( s) and total vol. of MeOH extracts

5)

Liquid-liquid partitioning with ethyl acetate (EtOAc)
a) Partition MeOH extracts with 3x200mL ACS grade EtOAc/ 700mL of
MeOH extracts
b) In large separatory funnel add:
-MeOH extracts (700mL)
-200mL EtOAc
-100mL brine soln
-50-100g NaCI
-1 OOmL diH20 (if needed to dissolve NaCI)
c) Agitate funnel to be sure contents are mixed well
d) Allow layers to separate for at least 30min. or until 2 distinct layers have
formed (record total separation time)
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e) Empty aqueous (MeOH) layer into large Erlenmyer flask then collect
organic (EtOAc) layer in another flask & record volume of EtOAc extract
f) Add aqueous layer back into sep. funnel and add another 200mL EtOAc
g) Repeat steps d. & e. to have a total of 3x200mL EtOAc partitions
h) Wash sep. funnel(s) with small amt. of EtOAc & add to collected extracts
i) Record total amount of EtOAc extracts and note color
6)

Dry EtOAc extracts with anhydrous sodium sulfate (Na2S04) overnight
under refridgeration

7)

Concentrate EtOAc extracts in recovery flask on rotovap
a) Filter extracts into recovery flask
b) Wash Na2S04 with EtOAc and filter wash into recovery flask with
extracts
c) Rotovap to dryness & repeat as needed until all extracts are
concentrated
d) Record consistency & color of concentrated crude extracts

8)

Remove remaining solvent with high vacuum pump for 3 hours -overnight
a) Record final weight of dried extract and note consistency and color

Isolation of annonacin from fruit extracts:
Use gravity silica gel (Merck, Silica Gel 60 F254) packed to 250mm in a 25mm
wide column. Volumes used are per -500mg of crude extract. Load crude
extract in EtOAc adding small amounts of MeOH as needed to fully dissolve
contents.
1)

Gradient solvent system for 1st column chromatography:
a)
b)
c)
d)
e)

2)

Hexane: EtOAc 5:1 (500ml)
Hexane: EtOAc 1:1 (200ml)
Hexane: EtOAc 1:2 (200ml)
100% EtOAc
(100ml)
5% MeOH in EtOAc (500ml)

Gradient solvent system for 2nd (and 3rd , if needed) column chromatography:
a) Hexane: EtOAc 1:1 (200ml)
b) Hexane: EtOAc 1:2 (300ml)
c) 5% MeOH in EtOAc (300ml)
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